Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance.
Schrank Z, Chhabra G, Lin L, Iderzorig T, Osude C, Khan N, Kuckovic A, Singh S, Miller RJ, Puri N.
Schrank Z, et al. Among authors: chhabra g.
Cancers (Basel). 2018 Jul 4;10(7):224. doi: 10.3390/cancers10070224.
Cancers (Basel). 2018.
PMID: 29973561
Free PMC article.
Review.